Science Explorer Back to mapMap
Institution · Go2 for Lung Cancer

Most cited papers from Go2 for Lung Cancer

What are the most cited papers from Go2 for Lung Cancer?

The most cited paper from Go2 for Lung Cancer is "Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation" (Christian Rolfo, Noy Meshulami, Alessandro Russo et al., 2021), with 54 citations. Next come "Including the patient voice in the development and implementation of patient‐reported outcomes in cancer clinical trials" (54) and "Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma" (52).

Showing 50 of 79 papers. Every paper with more than 0 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation Christian Rolfo, Noy Meshulami, Alessandro Russo et al. · Journal of Thoracic Oncology Open access 10 Nov 2021 54
2 Including the patient voice in the development and implementation of patient‐reported outcomes in cancer clinical trials Bonnie J. Addario, Jan Geißler, Marcia K. Horn et al. · Health Expectations Open access 13 Nov 2019 54
3 Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma Smita C. Banerjee, Noshin Haque, Elizabeth Schofield et al. · CHEST Journal Open access 16 Dec 2020 52
4 Responding empathically to patients: a communication skills training module to reduce lung cancer stigma Smita C. Banerjee, Noshin Haque, Carma L. Bylund et al. · Translational Behavioral Medicine Open access 21 Feb 2020 47
5 Patient value: Perspectives from the advocacy community Bonnie J. Addario, Ana Fadich, Jesme Fox et al. · Health Expectations Open access 20 Sep 2017 36
6 A 10-Year Cross-Sectional Analysis of Public, Oncologist, and Patient Attitudes About Lung Cancer and Associated Stigma Maureen Rigney, Eleni Rapsomaniki, Lisa Carter‐Harris et al. · Journal of Thoracic Oncology Open access Oct 2020 35
7 Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer Adam H. Fox, James R. Jett, Upal Basu Roy et al. · CHEST Journal Open access 26 Jun 2021 30
8 Reducing stigma triggered by assessing smoking status among patients diagnosed with lung cancer: De-stigmatizing do and don't lessons learned from qualitative interviews Jamie S. Ostroff, Smita C. Banerjee, Kathleen A. Lynch et al. · PEC Innovation Open access 4 Mar 2022 29
9 Effectiveness of Lung Cancer Screening Implementation in the Community Setting in the United States Amy L. Copeland, Angela Criswell, Andrew Ciupek et al. · Journal of Oncology Practice Open access 31 May 2019 26
10 Deploying Team Science Principles to Optimize Interdisciplinary Lung Cancer Care Delivery: Avoiding the Long and Winding Road to Optimal Care Raymond Uyiosa Osarogiagbon, Hector P. Rodríguez, Danielle Hicks et al. · Journal of Oncology Practice Open access 21 Sep 2016 26
11 An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease Tiziana Vavalà, Maureen Rigney, Maria Lucia Reale et al. · Respirology Open access 29 Oct 2020 24
12 The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer Barbara Jennifer Gitlitz, Silvia Novello, Tiziana Vavalà et al. · JTO Clinical and Research Reports Open access 24 May 2021 22
13 Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable Edward S. Kim, Upal Basu Roy, Jennifer Lynne Ersek et al. · Journal of Thoracic Oncology Open access 30 Jan 2019 22
14 Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors Heather S.L. Jim, Sarah L. Eisel, Aasha I. Hoogland et al. · Cancers Open access 31 Dec 2020 19
15 Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer Philip C. Mack et al. · Cancer Cell Open access 20 Apr 2022 18
16 Emphysema Detection in the Course of Lung Cancer Screening: Optimizing a Rare Opportunity to Impact Population Health James L. Mulshine et al. · Annals of the American Thoracic Society Open access 9 Dec 2022 16
17 The International Association for the Study of Lung Cancer Early Lung Imaging Confederation James L. Mulshine et al. · JCO Clinical Cancer Informatics Open access 6 Feb 2020 16
18 Characteristics of Patients With ROS1+ Cancers: Results From the First Patient-Designed, Global, Pan-Cancer ROS1 Data Repository Divya Ahuja Parikh, Guneet Walia, Janet Freeman‐Daily et al. · JCO Oncology Practice Open access 27 Dec 2019 15
19 The American Cancer Society National Lung Cancer Roundtable strategic plan: Lung cancer in women Leah Monique Backhus, Ching‐Fei Chang, Lori C. Sakoda et al. · Cancer Open access 20 Sep 2024 12
20 Sexual Health Assessment in Women with Lung Cancer study: Sexual health assessment in women with lung cancer Narjust Florez, Lauren Kiel, Kelly Meza et al. · Cancer 16 Oct 2023 11
21 Study protocol of a multiphase optimization strategy trial (MOST) for delivery of smoking cessation treatment in lung cancer screening settings Jamie S. Ostroff, Donna Shelley, Lou-Anne R. Chichester et al. · Trials Open access 17 Aug 2022 11
22 Lung cancer is a global epidemic and requires a global effort. Bonnie J. Addario · PubMed Open access Feb 2015 9
23 Real‐world analysis of the relationships between smoking, lung cancer stigma, and emotional functioning Kari Chansky, Maureen Rigney, Jennifer C. King · Cancer Medicine Open access 12 Jan 2024 8
24 Survivor and Caregiver Expectations and Preferences Regarding Lung Cancer Treatment Jana Wieland, Bradford S. Hoppe, Sarah M. Rausch-Osian et al. · International Journal of Particle Therapy Open access Sep 2019 8
25 Patient-reported impact of symptoms in lung cancer (PRISM-LC) Anika Varma, Jennifer S. Weinstein, Jamison Seabury et al. · Translational Lung Cancer Research Open access Jul 2023 7
26 The American Cancer Society National Lung Cancer Roundtable strategic plan: Implementation of high‐quality lung cancer screening Joelle Thirsk Fathi, Angela M. Barry, Grant M. Greenburg et al. · Cancer Open access 20 Sep 2024 6
27 Getting ready for prime time: Recommended adaptations of an Empathic Communication Skills training intervention to reduce lung cancer stigma for a national multi-center trial Smita C. Banerjee, Charlotte D. Malling, Megan Johnson Shen et al. · Translational Behavioral Medicine Open access 14 Aug 2023 6
28 Leveraging social media to increase lung cancer screening awareness, knowledge and uptake among high-risk populations (The INSPIRE-Lung Study): study protocol of design and methods of a community-based randomized controlled trial Lisa Carter‐Harris, Smita C. Banerjee, Robert S. Comer et al. · BMC Public Health Open access 26 May 2023 6
29 Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer Ananda Marina Rodilla et al. · Cancer Cell Open access 19 Oct 2023 5
30 The patient experience with shared decision-making in lung cancer: A survey of patients, significant others or care givers Laurie E. Gaspar, Howard West, Bonnie J. Addario et al. · Patient Experience Journal Open access 25 Apr 2018 5
31 Strategies for improving biomarker testing rates in non-small cell lung cancer in north America: a scoping review Ana S. Salazar, Jose Noy, John M. Reynolds et al. · Journal of Thoracic Disease Open access Oct 2025 4
32 Influences on Lung Cancer Screening Initiation and Retention in Rural Alabama Amy L. Copeland, Kathy Levy, Claudia M. Hardy et al. · Journal of Primary Care & Community Health Open access 2023 4
33 The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening Joelle Thirsk Fathi, Paul M. Cinciripini, Madeline J. DePrimo et al. · Cancer 10 Sep 2025 3
34 A New Framework for Co-Creating Telehealth for Cancer Care with the Patient Community Bonnie J. Addario, Violeta Astratinei, Louise Binder et al. · Patient Open access 26 Jul 2023 3
35 Improving Patient Advocacy in NCI Scientific Steering Committees and Task Forces Rick Bangs, Jean M Lynn, Evelyn Obot et al. · JNCI Journal of the National Cancer Institute Open access 6 May 2022 3
36 OA01.01 Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls Jorge E Gomez, Florian Krammer, Philip C. Mack et al. · Journal of Thoracic Oncology Open access Oct 2021 3
37 FP13.03 The Impact of the COVID-19 Pandemic on Lung Cancer Screening Programs in the United States Jennifer C. King, Angela Criswell, RICKY T. MOHON et al. · Journal of Thoracic Oncology Open access Oct 2021 3
38 The Role of Imaging in Lung Cancer Clifton F. Mountain, Kay E. Hermes · Cancer Imaging Book chapter 2008 3
39 Impact of air pollution and population vulnerability on cancer mortality in the United States: A scoping review Nan Ji, Shanada Monestime, Lori M. Rosman et al. · The Science of The Total Environment Open access 10 Dec 2025 2
40 Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection Julián Chavarriaga, Ahmad Mousa, Eshetu G. Atenafu et al. · Urologic Oncology Seminars and Original Investigations 27 Aug 2024 2
41 Utilizing a patient advocacy-led clinical network to engage diverse, community-based sites in implementation-effectiveness research Andrew Ciupek, Lou-Anne R. Chichester, Rashmi Acharya et al. · BMC Health Services Research Open access 5 Aug 2024 2
42 Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections Medha Somisetty et al. · Clinical Lung Cancer Open access 20 Jul 2024 2
43 Safety and Efficacy of Disulfiram in Hospitalized Patients with Moderate COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial Augusto César de Andrade Mota, Valdir C. Sant’Ana Filho, Carolyn M. Hendrickson et al. · medRxiv PreprintOpen access 26 Oct 2023 2
44 Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer Upal Basu Roy, Anne‐Marie Baird, Andrew Ciupek et al. · JTO Clinical and Research Reports Open access 23 Dec 2021 2
45 PD1.05 (also presented as P1.49): The Genomics of Young Emergent Lung Cancer Barbara Jennifer Gitlitz, Bonnie J. Addario, Alicia L. Sable-Hunt et al. · Journal of Thoracic Oncology Open access 22 Sep 2016 2
46 The American Cancer Society National Lung Cancer Roundtable strategic plan: Challenges in clinical guideline recommendations for biomarker testing in lung cancer Shetal A. Patel et al. · Cancer 12 May 2026 1
47 Leveraging Social Media to Achieve Population-Level Reach of Lung Cancer Screening-Eligible Individuals: A RE-AIM Framework Perspective Lisa Carter-Bawa, Jamie S. Ostroff, Susan M. Rawl et al. · Journal of Medical Internet Research Open access 20 Jan 2026 1
48 Unmet Support Needs in Cancer Navigation for Diverse Populations in Canada and the United States Shanada Monestime, Odinaka Oranekwu, Sydney Lampkin et al. · JCO Oncology Practice 8 Jan 2026 1
49 Confronting nihilism and stigma in lung cancer: The nurse practitioner's role in restoring hope and trust Lisa Carter-Bawa et al. · Journal of the American Association of Nurse Practitioners Open access 24 Dec 2025 1
50 Leveraging Patient Advocacy and Faith-Based Partnerships to Educate, Activate, and Prepare Black Communities to Be Screened for Lung Cancer Sydney J. Lloyd, Kathy Levy, Alan C. Boyd et al. · CHEST Journal 5 Dec 2024 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.